Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Hammett

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Addictive Behaviors|November 6, 2016
Characteristics, use patterns and perceptions of electronic cigarette users who were never traditional cigarette smokersErin Hammett, Susan Veldheer, Jessica Yingst, et al.
Tobacco Control|September 7, 2016
Should electronic cigarette use be covered by clean indoor air laws?Jessica M Yingst, Susan Veldheer, Erin Hammett, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 9, 2017
A Method for Classifying User-Reported Electronic Cigarette Liquid FlavorsJessica M Yingst, Susan Veldheer, Erin Hammett, et al.
Journal of the American Association of Nurse Practitioners|April 26, 2017
Measurement of exhaled breath carbon monoxide in clinical practice: A study of levels in Central Pennsylvania community membersShari Hrabovsky, Jessica M Yingst, Susan Veldheer, et al.
Medical Mycology|April 3, 2024
Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598Kenan Gu, Robert Spitz, Erin Hammett, et al.
Journal of Health Communication|March 27, 2018
Pilot Randomized Trial of an Automated Smoking Cessation Intervention via Mobile Phone Text Messages as an Adjunct to Varenicline in Primary CareJessica M Yingst, Susan Veldheer, Shari Hrabovsky, et al.
Journal of Hospital Medicine|January 26, 2018
TXT2STAYQUIT: Pilot Randomized Trial of Brief Automated Smoking Cessation Texting Intervention for Inpatient Smokers Discharged from the HospitalErin Hammett, Susan Veldheer, Shari Hrabovsky, et al.
Brain Research Bulletin|July 28, 2022
Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposureJessica M Yingst, Courtney Lester, Craig Livelsberger, et al.
BMC Public Health|January 21, 2017
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocolSophia I Allen, Jonathan Foulds, Gladys N Pachas, et al.
Plos One|November 2, 2022
The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trialJonathan Foulds, Susan Veldheer, Gladys Pachas, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Addictive Behaviors|November 6, 2016
Characteristics, use patterns and perceptions of electronic cigarette users who were never traditional cigarette smokersErin Hammett, Susan Veldheer, Jessica Yingst, et al.
Tobacco Control|September 7, 2016
Should electronic cigarette use be covered by clean indoor air laws?Jessica M Yingst, Susan Veldheer, Erin Hammett, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 9, 2017
A Method for Classifying User-Reported Electronic Cigarette Liquid FlavorsJessica M Yingst, Susan Veldheer, Erin Hammett, et al.
Journal of the American Association of Nurse Practitioners|April 26, 2017
Measurement of exhaled breath carbon monoxide in clinical practice: A study of levels in Central Pennsylvania community membersShari Hrabovsky, Jessica M Yingst, Susan Veldheer, et al.
Medical Mycology|April 3, 2024
Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598Kenan Gu, Robert Spitz, Erin Hammett, et al.
Journal of Health Communication|March 27, 2018
Pilot Randomized Trial of an Automated Smoking Cessation Intervention via Mobile Phone Text Messages as an Adjunct to Varenicline in Primary CareJessica M Yingst, Susan Veldheer, Shari Hrabovsky, et al.
Journal of Hospital Medicine|January 26, 2018
TXT2STAYQUIT: Pilot Randomized Trial of Brief Automated Smoking Cessation Texting Intervention for Inpatient Smokers Discharged from the HospitalErin Hammett, Susan Veldheer, Shari Hrabovsky, et al.
Brain Research Bulletin|July 28, 2022
Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposureJessica M Yingst, Courtney Lester, Craig Livelsberger, et al.
BMC Public Health|January 21, 2017
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocolSophia I Allen, Jonathan Foulds, Gladys N Pachas, et al.
Plos One|November 2, 2022
The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trialJonathan Foulds, Susan Veldheer, Gladys Pachas, et al.
Pageof 2